Skip to main content

Featured

The U.S. Is Banning Canadian Booze on Sept. 29 — Here's What It Means for Ontario's $1-Billion Industry

  LCBO shelves have been missing American bourbon and Napa wine since March 2025. In three weeks, the trade war flips direction — and this time it's Canadian producers, and the roughly 20,000 Ontarians who work for them, absorbing the hit. What's actually changing on Sept. 29 On Sept. 8, President Trump signed proclamations that ban a wide range of Canadian alcohol from entering the United States, effective 12:01 a.m. Eastern on Sept. 29. It's a different kind of measure than the tariffs Canadians have gotten used to reading about this year — this isn't a price increase, it's a door closed. Packaged beer, wine, cider, and spirits (including whisky, vodka, gin, rum, tequila and mezcal) are covered, alongside whey products, molasses, non-alcoholic beer, and larger motorcycles. Canadian alcohol previously imported but not yet cleared for consumption before Sept. 29 stays under the existing 50% duty instead of the outright ban. The White House's proclamation points ...
Post a Comment
Read more

article

Labels

Controversial Turkish Import Endangers Newborns in Alberta, Documents Reveal

 

Recent documents have raised alarming concerns over Alberta’s emergency importation of children’s pain medication from Turkey. Produced by Atabay Pharmaceuticals and sold under the brand name Parol Suspension, the drug is marketed at a concentration of 24 mg/ml—significantly lower than the 32 mg/ml concentration found in the standard, Canadian-authorized formulation.

Health experts and opposition critics warn that this altered concentration poses a twofold risk. First, the discrepancy could lead to dosing errors if parents and caregivers, accustomed to the standard formulation, misjudge the correct volume needed. Second, there are fears that the lower concentration may lead to the clogging of hospital feeding tubes—a critical concern for vulnerable newborns.

Alberta Blue Cross has informed pharmacists that Parol must be dispensed with enhanced caution, requiring additional education on its proper use. Critics argue that the rushed procurement—amounting to approximately $80 million—exemplifies a misstep in prioritizing political expedience over stringent safety protocols. With traditional supplies of children’s pain medications already in short supply, many worry that this controversial alternative might jeopardize the health of Alberta’s youngest patients.

Further review and tighter regulatory oversight are now being called for, as stakeholders demand that the province safeguard the well-being of newborns and ensure that emergency measures do not compromise pediatric care.

Labels:

Comments

Post a Comment